APA (7th ed.) Citation

Okerberg, C. K., Williams, L. A., Kilgore, M. L., Kim, C. H., Marques, M. B., Schwartz, J., & Pham, H. P. (2016). Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation. Vox Sanguinis, 111(3), 292. https://doi.org/10.1111/vox.12417

Chicago Style (17th ed.) Citation

Okerberg, C. K., L. A. Williams, M. L. Kilgore, C. H. Kim, M. B. Marques, J. Schwartz, and H. P. Pham. "Cryoprecipitate AHF Vs. Fibrinogen Concentrates for Fibrinogen Replacement in Acquired Bleeding Patients - an Economic Evaluation." Vox Sanguinis 111, no. 3 (2016): 292. https://doi.org/10.1111/vox.12417.

MLA (9th ed.) Citation

Okerberg, C. K., et al. "Cryoprecipitate AHF Vs. Fibrinogen Concentrates for Fibrinogen Replacement in Acquired Bleeding Patients - an Economic Evaluation." Vox Sanguinis, vol. 111, no. 3, 2016, p. 292, https://doi.org/10.1111/vox.12417.